Trial Profile
A study assessing P2Y12 inhibitor use in patients undergoing percutaneous coronary intervention from a large single-center registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2016 New trial record